Research never stops


Feb 09, 2017

Novo A/S becomes new long-term strategic shareholder in Evotec

Hamburg, Germany, 09 February 2017:
Evotec AG today announced that it resolved on a capital increase from its authorised capital against cash.

- read more
Jan 26, 2017

Cyprotex, an Evotec company, expands into new UK facility at Alderley Park

Hamburg, Germany - 26 January 2017: Evotec AG today announced that Cyprotex, a company wholly owned by Evotec AG, has completed the relocation of its UK operations from Macclesfield to Alderley Park.

- read more
Jan 30, 2017

Evotec to attend three upcoming investor conferences

Hamburg, Germany, 30 January 2017:


Jefferies' 2017 Celgene Collaborators Summit, New York City, USA
Date: Tuesday, 21 February 2017
Venue: New York City, USA

- read more
Jan 19, 2017

Evotec enters into an integrated drug discovery collaboration with Asahi Kasei Pharma (Japan)

Hamburg, Germany, 19 January 2017: Evotec AG today announced it has entered into an integrated drug discovery collaboration on an ion channel target with Asahi Kasei Pharma Corporation, a wholly owned subsidiary of Asahi Kasei Corporation, Tokyo, Japan.

- read more
Jan 17, 2017

Evotec and MaRS Innovation establish strategic partnership to launch Fibrocor Therapeutics

Toronto, Canada and Hamburg, Germany, 17 January 2017: Evotec AG and MaRS Innovation today announced the launch of Fibrocor Therapeutics LP, a Toronto-based company focused on developing first-in-class therapeutics targeting fibrotic diseases.

- read more
Jan 12, 2017

HaplogenĀ“s novel antiviral target partnered with Evotec published in 'Nature'

Jan 09, 2017

Evotec and Eternygen to develop novel metabolic disease therapy